Could Single-Cell RNA Sequencing Help Personalize Multiple Myeloma Treatment? - Samir Parekh, MD
Samir Parekh, MBBS, associate professor of medicine, hematology, medical oncology, and oncological sciences at the Icahn School of Medicine at Mount Sinai, highlights a study that shows that patients with relapsed multiple myeloma may need highly individualized therapy to overcome the complexity of relapsed disease. The researchers found that single-cell RNA sequencing can better characterize patients and potentially improve treatment in a more personalized manner. Results of the study were presented at the 2017 American Society of Hematology Annual Meeting and Exposition in Atlanta.
- Samir Parekh, MBBS, Associate Professor, Medicine, Hematology, Medical Oncology, Oncological Sciences, Icahn School of Medicine at Mount Sinai
Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T
Nov 04, 2022 View All Press Releases
